Amgen (AMGN) Return on Capital Employed (2009 - 2026)

Amgen (AMGN) has reported Return on Capital Employed for 17 consecutive years, with 15.87% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Capital Employed rose 486.0% year-over-year to 15.87%; the TTM figure through Mar 2026 stood at 15.87% (up 486.0% YoY), while the FY2025 annual figure was 13.82%, up 365.0% from the prior year.
• Return on Capital Employed came in at 15.87% for Q1 2026 at Amgen, up from 14.0% in the prior quarter.
• The five-year high for Return on Capital Employed was 20.44% in Q3 2022, with the low at 8.79% in Q2 2024.
• Average Return on Capital Employed over 5 years is 13.55%, with a median of 12.9% recorded in 2025.
• Across the five-year window, Return on Capital Employed jumped 499 bps in 2022 and slumped 917 bps in 2023, its largest moves.
• Year by year, Return on Capital Employed stood at 19.63% in 2022, then plunged by 47 bps to 10.47% in 2023, then advanced by 2 bps to 10.63% in 2024, then soared by 32 bps to 14.0% in 2025, then gained by 13 bps to 15.87% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 15.87%, 14.0%, and 12.9% for Q1 2026, Q4 2025, and Q3 2025 respectively.